# Stress Cardiomyopathy Following Multivisceral Transplantation: A Case Report

## TL;DR

A rare heart condition called stress cardiomyopathy occurred in a patient during a complex multivisceral transplant surgery and was successfully managed with timely intervention.

## Contribution

This is the first reported case of stress cardiomyopathy following multivisceral transplantation.

## Key findings

- Stress cardiomyopathy can occur during MVT due to extreme physiological stress.
- Use of venovenous extracorporeal membrane oxygenation support contributed to a favorable outcome.
- Early diagnosis and intervention are crucial for managing stress cardiomyopathy in high-risk surgeries.

## Abstract

Multivisceral transplantation (MVT) is an extraordinarily complex surgical procedure that imposes significant physiological stress driven by hemodynamic instability, fluid shifts, and severe bleeding. These factors can profoundly affect cardiovascular function and increase the risk of complications. Stress cardiomyopathy (Takotsubo syndrome), a transient non-ischemic heart failure characterized by acute left ventricular dysfunction, is a recognized complication of major surgeries but has not previously been reported in the context of MVT. This case report describes the occurrence, diagnosis, perioperative management, and favorable outcome of stress cardiomyopathy in a patient undergoing MVT with intraoperative venovenous extracorporeal membrane oxygenation support. It highlights the diagnostic criteria for stress cardiomyopathy, including echocardiographic findings and the application of the InterTAK score. It emphasizes the critical importance of heightened awareness, vigilance, and timely intervention to achieve a favorable clinical outcome.